Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C

This publication has 14 references indexed in Scilit:

• Hepatitis C virus-associated B-cell non-Hodgkin lymphomas
  Hematology-American Society Hematology Education Program, 2014
• Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study
  American Journal of Hematology, 2014
• Molecular pathogenesis of mantle cell lymphoma
  Journal of Clinical Investigation, 2012
• Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium
  Clinical Gastroenterology and Hepatology, 2008
• Hepatitis C and Risk of Lymphoma: Results of the European Multicenter Case-Control Study EPILYMPH
  Gastroenterology, 2006
• Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic Studies
  Cancer Epidemiology, Biomarkers & Prevention, 2006
• Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas
  Leukemia, 2004
• B‐cell non‐Hodgkin's lymphoma and hepatitis C virus infection: A systematic review
  International Journal of Cancer, 2004
• Treatment of HCV-Related Mantle-Cell Lymphoma with Ribavirin and Pegylated Interferon Alfa
  New England Journal of Medicine, 2003
• Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection
  New England Journal of Medicine, 2002